MedPath

The effect of a self controlled dose of Levothyroxine on the quality of life and thyroid stimulating hormone in patients treated for hypothyroidism: a randomized, double blind, consecutive study.

Conditions
slow-acting thyroid gland
10043739
Registration Number
NL-OMON36807
Lead Sponsor
Maasstadziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

- Primary Hypothyroidism
- Euthyroidism
- Stable dose of Levothyroxine for over 6 months
- Age 18-75
- Own wish to change dose of medication

Exclusion Criteria

Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary endpoint: QoL by SF/RAND 36.<br /><br>Thereby: Symptoms and complaints by symtomlist hypothyroidism, general symptom<br /><br>list and Hospital anxiety and depression scale.<br /><br>TSH,T4 and T3.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints:<br /><br>Influence of BMI on QoL. Clinical parameters like heartbeat, blood pressure and<br /><br>laboratory findings.</p><br>
© Copyright 2025. All Rights Reserved by MedPath